以患者為中心的結果研究 SCIESSCI

期刊簡介預計審稿時間： 12周，或約稿

The Patient provides a venue for scientifically rigorous, timely, and relevant research to promote the development, evaluation and implementation of therapies, technologies, and innovations that will enhance the patient experience. It is an international forum for research that advances and/or applies qualitative or quantitative methods to promote the generation, synthesis, or interpretation of evidence.

The journal has specific interest in receiving original research, reviews and commentaries related to qualitative and mixed methods research, stated-preference methods, patient reported outcomes, and shared decision making.

Advances in regulatory science, patient-focused drug development, patient-centered benefit-risk and health technology assessment will also be considered.

Additional digital features (including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations) can be published with articles; these are designed to increase the visibility, readership and educational value of the journal’s content. In addition, articles published in The Patient may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand important medical advances.

All manuscripts are subject to peer review by international experts.

《患者》雜志為科學嚴謹、及時和相關的研究提供了一個平臺，以促進治療、技術和創新的開發、評估和實施，從而改善患者的體驗。這是一個國際研究論壇，旨在推進和/或應用定性或定量方法來促進證據的生成、綜合或解釋。

該雜志特別希望收到與定性和混合方法研究、陳述偏好方法、患者報告結果和共同決策相關的原創研究、評論和評論。

監管科學、以患者為中心的藥物開發、以患者為中心的效益風險和健康技術評估方面的進展也將得到考慮。

其他數字功能（包括動畫摘要、視頻摘要、幻燈片、音頻幻燈片、教學視頻、信息圖表、播客和動畫）可以與文章一起發布；這些旨在提高期刊內容的知名度、讀者群和教育價值。此外，《患者》雜志上發表的文章可能附有通俗易懂的語言摘要，以幫助對該領域有一定了解但不具備深入專業知識的讀者了解重要的醫學進展。

所有稿件均需經過國際專家的同行評審。

《Patient-patient Centered Outcomes Research》(以患者為中心的結果研究)編輯部通訊方式為5 THE WAREHOUSE WAY, NORTHCOTE, NEW ZEALAND, AUCKLAND, 0627。如果您需要協助投稿或潤稿服務，您可以咨詢我們的客服老師。我們專注于期刊咨詢服務十年，熟悉發表政策，可為您提供一對一投稿指導，避免您在投稿時頻繁碰壁，節省您的寶貴時間，有效提升發表機率，確保SCI檢索（檢索不了全額退款）。我們視信譽為生命，多方面確保文章安全保密，在任何情況下都不會泄露您的個人信息或稿件內容。